$Pistol Pete$, $Mick$ & Friends Stock Picks /news, DD and charts

[1center]

$SPRWF 1.23 ^7% Supreme Pharmaceuticals’ (OTC: SPRWF) (TSXV: FIRE) wholly owned 7ACRES subsidiary recently received approval from Health Canada to begin cultivation at its 30,000 square-foot flowering rooms at the company's hybrid grow facility. The additional flowering rooms increases the size of 7ACRES' flowering facility to 40,000 square feet. 7ACRES, and thus Supreme, also has its footing in oils via a retail partnership with Aurora Cannabis (TSX: ACB) (OTC: ACBFF). In its fourth-quarter financial results, Aurora said sales of dried medical cannabis and cannabis oils contributed $5.6 million to revenues, of which $0.4 million (7.1%) was generated in Germany and $5.2 million in Canada (http://nnw.fm/MOgY2).
Adoption of cannabis oil continues to increase as a preferred alternative to cannabinoid consumption, providing cannabis cultivators with an unprecedented market opportunity paced by rising consumer demand.
https://www.networknewswire.com/rising-demand-cannabis-oils-pushes-canadas-producers-overdrive/

Supreme Commences Production in New Flowering Rooms
November 07, 2017
http://www.supreme.ca/news/press-release-details/2017/Supreme-Commences-Production-in-New-Flowering-Rooms/default.aspx

Supreme Crosses Important Revenue Milestone
October 03, 2017
http://www.supreme.ca/news/press-release-details/2017/Supreme-Crosses-Important-Revenue-Milestone/default.aspx

Supreme Completes First Sales with Aurora Cannabis
September 05, 2017
http://www.supreme.ca/news/press-release-details/2017/Supreme-Completes-First-Sales-with-Aurora-Cannabis-/default.aspx

more
http://www.supreme.ca/investors/overview/default.aspx

Filings on Sedar
http://sedar.com/DisplayProfile.do?lang=EN&issuerType=03&issuerNo=00006000